Granahan Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,434	Closed	-$9.35M	–	216
2017 Q4	$9.35M	Sell	10,434 -21,819	-68%	-$12.9M	0.74%	43
2017 Q3	$11.6M	Buy	32,253 +1,640	+5%	+$513K	0.97%	28
2017 Q2	$8.98M	Sell	30,613 -6,885	-18%	-$1.99M	0.83%	35
2017 Q1	$13.2M	Sell	37,498 -83,589	-69%	-$18.8M	1.32%	17
2016 Q4	$22.3M	Sell	121,087 -11,788	-9%	-$2.4M	0.77%	41
2016 Q3	$34.2M	Buy	132,875 +853	+0.6%	+$220K	1.12%	17
2016 Q2	$28.2M	Sell	132,022 -4,767	-3%	-$1.07M	1.03%	23
2016 Q1	$28.2M	Sell	136,789 -2,021	-1%	-$388K	1.03%	26
2015 Q4	$35.1M	Sell	138,810 -15,835	-10%	-$3.26M	1.21%	12
2015 Q3	$25.4M	Buy	154,645 +7,127	+5%	+$1.26M	0.79%	38
2015 Q2	$27.7M	Sell	147,518 -278	-0.2%	-$47.8K	0.78%	41
2015 Q1	$24.4M	Sell	147,796 -86,203	-37%	-$17.7M	0.7%	51
2014 Q4	$54.4M	Buy	233,999 +4,467	+2%	+$955K	1.59%	4
2014 Q3	$41.6M	Sell	229,532 -15,423	-6%	-$2.95M	1.28%	12
2014 Q2	$47.1M	Sell	244,955 -1,309	-0.5%	-$232K	1.37%	10
2014 Q1	$44.8M	Buy	246,264 +31,070	+14%	+$6.15M	1.21%	11
2013 Q4	$36.6M	Buy	215,194 +34,205	+19%	+$5.52M	0.94%	27
2013 Q3	$28.4M	Sell	180,989 -11,424	-6%	-$2.11M	0.75%	46
2013 Q2	$33.3M	Buy	+192,413	New	+$29.5M	0.96%	25